Last reviewed · How we verify
OAC monotherapy
At a glance
| Generic name | OAC monotherapy |
|---|---|
| Sponsor | St. Antonius Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation (NA)
- Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure (PHASE4)
- Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage (NA)
- Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |